<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Fragment-Based Drug Discovery (FBDD)</title>
    <!-- Load the Inter font from Google Fonts -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600;700&display=swap" rel="stylesheet">
    <!-- Load Tailwind CSS -->
    <script src="https://cdn.tailwindcss.com"></script>
    <style>
        body {
            font-family: 'Inter', sans-serif;
        }
    </style>
</head>
<body class="bg-gray-100 text-gray-800 p-4 sm:p-8">

    <!-- Main content container with a rounded, floating effect -->
    <div class="container mx-auto max-w-6xl bg-white rounded-2xl shadow-xl p-6 sm:p-10">
        
        <!-- Main Title -->
        <h1 class="text-4xl sm:text-5xl font-extrabold text-center text-blue-800 mb-4 sm:mb-6">
            Fragment-Based Drug Discovery (FBDD)
        </h1>
        <p class="text-lg text-center text-gray-600 mb-8 sm:mb-12">
            A modern paradigm for developing potent, high-quality therapeutics.
        </p>

        <!-- FBDD Concepts and Stages Container -->
        <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-6 sm:gap-8">

            <!-- Card 1: What is FBDD? -->
            <div class="bg-blue-50 p-6 rounded-xl shadow-md transition-transform transform hover:scale-105">
                <h2 class="text-2xl font-bold text-blue-700 mb-2">1. What is FBDD?</h2>
                <p class="text-gray-700">
                    FBDD is a modern approach that starts by screening a library of very small, low-molecular-weight fragments. These fragments, typically defined by the **"Rule of 3,"** bind to a target protein with low affinity. The method's power lies in rationally building these weakly binding fragments into a highly potent and selective drug candidate.
                </p>
            </div>

            <!-- Card 2: High Hit Rate -->
            <div class="bg-purple-50 p-6 rounded-xl shadow-md transition-transform transform hover:scale-105">
                <h2 class="text-2xl font-bold text-purple-700 mb-2">2. High Hit Rate</h2>
                <p class="text-gray-700">
                    Due to their small size, fragments have a higher chance of fitting into a protein's binding pocket. This leads to a much higher "hit rate" compared to traditional High-Throughput Screening (HTS), which tests larger, more complex molecules.
                </p>
            </div>

            <!-- Card 3: Molecular Efficiency -->
            <div class="bg-emerald-50 p-6 rounded-xl shadow-md transition-transform transform hover:scale-105">
                <h2 class="text-2xl font-bold text-emerald-700 mb-2">3. Molecular Efficiency</h2>
                <p class="text-gray-700">
                    FBDD is based on the principle of **ligand efficiency**. Starting with a small, efficient fragment allows medicinal chemists to build an optimized, high-quality molecule with better properties from the ground up, reducing the risk of a poor drug.
                </p>
            </div>

            <!-- Card 4: Fragment Library Design -->
            <div class="bg-amber-50 p-6 rounded-xl shadow-md transition-transform transform hover:scale-105">
                <h2 class="text-2xl font-bold text-amber-700 mb-2">4. Fragment Library Design</h2>
                <p class="text-gray-700">
                    A small, diverse library of 500-2,000 fragments is carefully curated. These fragments are chosen to satisfy the **"Rule of 3"** and represent a wide range of chemical motifs, providing a solid foundation for drug design.
                </p>
            </div>

            <!-- Card 5: Screening for Hits -->
            <div class="bg-red-50 p-6 rounded-xl shadow-md transition-transform transform hover:scale-105">
                <h2 class="text-2xl font-bold text-red-700 mb-2">5. Screening for Hits</h2>
                <p class="text-gray-700">
                    Because fragment binding is weak, highly sensitive **biophysical screening methods** are used to detect hits. Common techniques include NMR Spectroscopy, X-ray Crystallography, and Surface Plasmon Resonance (SPR).
                </p>
            </div>

            <!-- Card 6: Fragment Elaboration & Linking -->
            <div class="bg-sky-50 p-6 rounded-xl shadow-md transition-transform transform hover:scale-105">
                <h2 class="text-2xl font-bold text-sky-700 mb-2">6. Fragment Elaboration & Linking</h2>
                <p class="text-gray-700">
                    Once validated, hit fragments are converted into a more potent lead compound. This is done either by **elaboration** (building upon the fragment) or **linking** two or more fragments together to create a single, more potent molecule.
                </p>
            </div>

        </div>

    </div>

</body>
</html>
